Psyence Biomedical Ltd. (PBM)

0.62

-0.04 (-5.34%)

At close: Mar 28, 2025, 3:06 PM

Psyence Biomedical Ltd. Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21
Net Income	-51.16M	8.01M	8.23M
Depreciation & Amortization	240.00	n/a	n/a
Stock-Based Compensation	317.88K	221.29K	332.07K
Other Working Capital	-1.28M	-54.44K	-504.88K
Other Non-Cash Items	49.07M	-8.48M	-8.56M
Deferred Income Tax	n/a	n/a	n/a
Change in Working Capital	-1.17M	-54.44K	-504.88K
Operating Cash Flow	-2.95M	-519.6K	-839.17K
Capital Expenditures	-5.73K	n/a	n/a
Acquisitions	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	-255M
Sales Maturities Of Investments	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-32.04K
Investing Cash Flow	-5.73K	n/a	-255M
Debt Repayment	2.35M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a
Other Financial Acitivies	n/a	1.17M	-1.63M
Financial Cash Flow	2.35M	1.17M	256.49M
Net Cash Flow	-601.09K	-519.61K	-4.16M
Free Cash Flow	-2.95M	-519.6K	-839.17K